Growth curve of murine xenotropic leukemia virus-related virus grown in Chinese hamster ovary cells  by Ma, Rong et al.
Available online at www.sciencedirect.comScienceDirect
Journal of the Chinese Medical Association 77 (2014) 44e48
www.jcma-online.comOriginal Article
Growth curve of murine xenotropic leukemia virus-related virus grown in
Chinese hamster ovary cells
Rong Ma a, Ming-Gang Bi b, Xiao-Lan Cui a,*
a Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China
b Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Received October 19, 2012; accepted May 15, 2013AbstractBackground: Murine xenotropic leukemia virus-related virus (XMulV) is used as a model virus in the evaluation of viral inactivation in Chinese
hamster ovary (CHO) cell-derived pharmaceutical proteins. Mus dunni cells and mink lung cells are used to produce XMulV particles. In
consideration of the characteristics of XMulV, we tried to propagate the viruses on CHO cells, a nonmurine cell line.
Methods: The viruses were harvested from CHO cells from Day 2 to Day 7 postinfection, and reverse transcription-quantitative polymerase chain
reaction was performed to quantify the viruses on different days. A cell-based infectivity assay was used to evaluate the XMulV titers.
Results: The content of the XMulV virions began to increase on Day 5 and grew exponentially from Day 6 to Day 7 postinfection. The growth
curve was a typical single-step growth curve. Titers of the viral stock harvested on Day 7 were assayed on PG-4 cells, and the titers were
8.78  0.25 log10 PFU/mL.
Conclusion: Based on these data, we conclude that CHO cells could be a host cell line for XMulV particles. XMulV produced on Day 7 in CHO
cells could be used at a laboratory scale for the evaluation of XMulV clearance in pharmaceutical proteins derived from CHO cells.
Copyright  2013 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Xenotropic murine leukemia virus-related virus (XMulV) is
a kind of gamma retrovirus. Although derived from endoge-
nous sequences of inbred mice, the virus does not exogenously
infect mouse cells, except certain cells of wild mouse origin
such asMus dunni cells. Thus, the virus is called “xenotropic.”
XMulV has a dimer genomic RNA, which is surrounded by a
capsid. It is typically used as a model virus in the evaluation of
viral inactivation in CHO-derived biological products. Host
organisms of XMulV include M. dunni cells, mink lung cells,
and other nonmurine cells. The virus produces foci of round
cells on mink lung cells MiCl1 and plaque-like foci on feline* Corresponding author. Dr. Xiaolan Cui, Institute of Chinese Materia
Medica, China Academy of Chinese Medical Sciences, Dongzhimennei South
Street 16th, Beijing 100700, China.
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1726-4901/$ - see front matter Copyright  2013 Elsevier Taiwan LLC and the C
http://dx.doi.org/10.1016/j.jcma.2013.09.005cell line, PG-4. Both the MiCl1 cells and the PG-4 cells are
sarcoma virus-positive and leukemia virus-negative cell lines,
which are abbreviated as SþL.
The Chinese hamster ovary (CHO) cell line is one of the
nonmurine cell lines and is the cell line most widely used for
the production of pharmaceutical proteins. Early studies have
demonstrated that there are endogenous gamma retroviruses in
CHO cells.1 This revealed the fact that gamma retrovirus could
grow in CHO cells. In addition, there is no cytopathic effect on
CHO cells. Thus, it is beneficial for the virus to grow in CHO
cells.
In this study, we investigated the development of XMulV in
CHO cells by SYBR Green fluorescence quantitative poly-
merase chain reaction (qPCR) and drew a growth curve of the
virus cocultured with CHO cells from Day 2 to Day 7. In order
to examine the activity of XMulV harvested from CHO cells, a
cell-based infectivity assay, the PG-4 SþL assay, was
performed.hinese Medical Association. All rights reserved.
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Bi, and the growth media for the cells were Dulbecco’s
modified Eagle’s medium (DMEM)/F12 (1:1, HyClone, UT,
USA) with 10% fetal bovine serum (FBS). The cells were
cultured at 37C in 5% CO2 environment and passaged two or
three times per week.
PG-4, a feline brain cell line (SþL), was purchased from
the American Type Culture Collection (ATCC; Catalog No.
CRL-2032). The cells are adherent astrocytes, and were grown
in modified McCoy’s 5A medium (Invitrogen, Carlsbad, CA,
USA) with 10% FBS and cultured at 37C in 5% CO2 envi-
ronment, and were passaged with 0.25% trypsin solution two
or three times weekly.2.2. VirusThe murine xenotropic leukemia virus-related virus, strain
pNFS Th-1, was purchased from the ATCC (Catalog No.VR-
1447).2.3. Virus propagation on CHO cellsCHO cells were seeded into a tissue culture flask (25 cm2) in
triplicate at a density of 5  105 per mL. After cultivating for
24 hours, the cells were inoculated with 1 mL of 10-fold diluted
XMulV stock (from the ATCC) containing 8.0 mg/mL of pol-
ybrene (Sigma-Aldrich, St. Louis, MO, USA). After 1.5 hours
of adsorption, another 9 mL of DMEM/F12 (1:1) with 5% FBS
was added. The cocultivation lasts for 7 days. On Day 7, the
coculture samples were harvested and resuspended in 1 mL of
noncomplete DMEM/F12 medium (1:1). The suspension was
frozen-thawed repetitively, and then the XMulV supernatant
was obtained by ultracentrifugation. The suspension served as a
viral stock and was used in the following experiments.2.4. Cultivation of XMulV in CHO cells from Day 2 to
Day 7CHO cells were seeded into six-well plates in triplicate at a
density of 5  104 per well. After 24 hours of cultivation, the
cells were inoculated with 0.5 mL of 10-fold diluted XMulV
stock (prepared as described in the section “Virus propagation
on CHO cells”), which contained 8.0 mg/mL of polybrene.
After 1.5 hours of adsorption, 3.5 mL of DMEM/F12 (1:1)
medium with 5% FBS was added. The coculture test samples
were harvested on Day 2, Day 3, Day 4, Day 5, Day 6, and
Day 7, respectively.2.5. Total RNA extractionTotal RNA was extracted from the samples prepared as
described in the section “Cultivation of XMulV in CHO cells
from Day 2 to Day 7” using Trizol (Invitrogen), chloroform,isopropanol, and 75% alcohol. Then the RNAwas dissolved in
0.1% DEPC (diethyl pyrocarbonate)-processed water.2.6. Reverse transcription-qPCR
2.6.1. Reverse transcription reaction
Total RNA was transcribed into cDNA immediately using
the First Strand cDNA Synthesis Kit (Toyobo, Tokyo, Japan).
Briefly, total RNA in DEPC-processed water was added to 5
reverse transcription (RT) reaction mix, resulting in a final
concentration of 25 mM MgCl2 10 mM dNTP mixture 10 mM
reverse primer and 0.5 U/mL RNase inhibitor. Reformative
MMLV had a final concentration of 0.5 U/mL. There was no
template in negative control. After a 5-minute incubation at
65C of RNA denaturation, the RT buffers were added, and the
tubes were cooled to 42C for RT. Each sample was set up in
triplicate.
2.6.2. PCR reaction
In PCR reaction, an equal volume cDNA was added to 2
PCR mixture. To amplify the XMulV gene, part of the XMuLV
genomewas sequenced. Two primers were used for sequencing:
50-TGCCCTTTACCCTGCTCTTACCC-30 (forward) and 50-
TGC CCCGCAAGCGAGACAC-30 (reverse), corresponding
to positions 1020e2633 of the gag gene sequence in GenBank
(Nucleotide Accession Number: JF908816.1). The size of the
gag gene product was 239 bp. Primers for the gene b-actin of
CHO cells (Nucleotide Accession Number: U20114.1) were 50-
CCCTGAAGTACCCCATTGAACACG-30 (forward) and 50-
GATAGA ACG GCAGAAGAA AGA CAA-30 (reverse). The
size of the b-actin product was 251 bp. Amplicons of the two
geneswere obtained by SYBRGreen real-time PCRMasterMix
(Toyobo) using the iQ5.0 real-time PCR detection system (Bio-
Rad Laboratories, Berkeley, CA, USA). For the gag gene, the
amplification began with a 10-minute incubation at 95C to
predegeneration, followed by 40 cycles of denaturation at 95C
for 15 seconds, annealing at 55.8C for 15 seconds, and exten-
sion at 72C for 45 seconds, then a cycle of terminal extension at
72C for 6 minutes. For the b-actin gene, the procedures of
amplification were the same as that of the gag gene, except for
the annealing temperature. For the b-actin gene, it was 55C.
Each sample was detected in three instances at different times.2.7. PG-4 cell SþL assayPG-4 cells were seeded into the six-well plate at a density
of 3  105 per well in 4.0 mL of the growth medium. The
plates were incubated at 37C in 5% CO2 environment for
24 hours. Then the media were replaced with 10-fold diluted
serial solutions from 105 to 107 folds of the XMulV stock
(prepared as described in the section “Virus propagation on
CHO cells”), which contained 8.0 mg/mL polybrene. Then,
0.5 mL of each diluted solution was inoculated into each of the
three replicate wells. A negative control group was also pre-
pared. After 1.5 hours of adsorption, another 3.5 mL of the
maintenance medium was added. On Day 1 and Day 4 of
inoculation, the medium was replaced with fresh medium. On
Fig. 1. Identification of amplified products by SYBR Green RT-qPCR. Total RNAwas extracted from coculture samples. RT-qPCR assay was performed to detect
the gag gene of XMulV, using b-actin as an internal reference. (A) Amplification chart of gag gene. (B) Amplification chart of b-actin. (C) Melt curve of gag gene.
(D) Melt curve of b-actin. RT-qPCR ¼ reverse transcription-quantitative polymerase chain reaction; XMulV ¼ xenotropic murine leukemia virus-related virus.
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(PFU) in each diluted group were recorded.
Viral titers of XMulV were calculated according to the
amount of plaques formed on PG-4 cells. The PFU of XMulV
was calculated using the following formula:
PFU per mL¼ dilution folds
mean of plaques in replicate wells
 ðvolume of viral suspensionÞ1Table 1
Relative quantity of gag RNA of XMulV inoculated in CHO cells from Day 2
to Day 7.
Days Density of CHO cell (per mL) RNA content Foldsa pb
Day 2 (5.21  0.14)  104 0.0179  0.011 1 d
Day 3 (6.79  0.22)  104 0.0242  0.007 1.36 0.479
Day 4 (1.34  0.46)  105 0.0301  0.013 1.68 0.427
Day 5 (2.35  0.52)  106 0.0626  0.021 3.51 0.117
Day 6 (2.12  0.21)  106 0.0706  0.090 3.96 0.497
Day 7 (2.01  0.19)  106 0.2479  0.004 13.89 0.001
CHO ¼ Chinese hamster ovary; XMulV ¼ xenotropic murine leukemia virus-
related virus.
a The fold was calculated as follows: RNA contents on Day 3, Day 4, Day 5,
Day 6, and Day 7 divided that on Day 2, respectively.
b p value was obtained by Student’s t-test, by which RNA content of other
days compared with the 2nd day. Each sample was set up in triplicate.2.8. Statistical analysisRelative quantities of XMulV were calculated by the
2DDCt method using the reference gene as a calibrator, and
the data were compared using Student’s t test. Significance
was set at p < 0.05.Fig. 2. Growth curve of XMulV cultivated in CHO cells from Day 2 to Day 7.
XMulV particles were inoculated onto CHO cells, and the cell cultures were
harvested on Day 2, Day 3, Day 4, Day 5, Day 6 and Day 7, respectively.
Reverse transcription-qPCR assay was performed, and relative quantification
method was used to calculate the content of gag RNA. The growth curve of
XMulV particles cultured in CHO cells from Day 2 to Day 7 fitted an expo-
nential equation, and R2 of the exponential fitting was 0.9125. CHO ¼ Chinese
hamster ovary; qPCR ¼ quantitative polymerase chain reaction;
XMulV ¼ xenotropic murine leukemia virus-related virus.
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Day 7The PCR amplification curve and the melting curve of the
two genes are shown in Fig. 1. The RNA content of the gag gene
is presented in Table 1. The relative content of the gag gene
began to increase on Day 5, and it was 13 times higher on Day 7
than on Day 2. The gene content on Day 7 was significantly
higher than that on Day 2 ( p < 0.01). The growth curve of
XMulV cultivated in CHO cells is shown in Fig. 2. The devel-
opment of XMulV in CHO cells was in line with an exponential
trend, and the R2 of the exponential equation was 0.9125.3.2. Titer of XMulV observed on PG-4 cellsFig. 3. Plaques formed on PG-4SþL cells ( 40magnification). (A)Negative
control. Instead of XMulV particles, PG-4 cells were infected with noncomplete
media. (B) PG-4 cellswere infectedwith 106-fold dilution serial ofXMulV stock
solution. (C) PG-4 cells were infected with 107-fold dilution serial of XMulV
stock solution. XMulV ¼ xenotropic murine leukemia virus-related virus.Plaques were read using a microscope at 40 magnification
(Model DP-72, Olympus, Tokyo, Japan), and the plaques
formed in different diluted solutions are shown in Fig. 3.
Plaques in the 105-fold and the 106-fold dilution serials
were too numerous to count. Titer was calculated according to
the number of plaques in the 107-fold diluted viral solution,
and the viral titer was 8.78  0.25 log10 PFU/mL.
4. Discussion
XMulV is a gamma retrovirus. It was previously believed to
be a noninfectious retrovirus, but currently it has proven to be
an infectious human virus2e4: the virus was detected in the
tissue of patients with chronic fatigue syndrome. However, its
viral classification and presence in chronic fatigue patients
remain controversial.5 XMulV is used as a model virus in the
evaluation of retroviral clearance in CHO-derived pharma-
ceutical proteins.
At present, M. dunni cells and mink lung cells are used to
propagate the XMulV particles, and other host cells of this
viral particle have not been studied. For the “xenotropic”
character of the virus, we considered using CHO cells to
propagate the virus. The CHO cell line, which is a nonmurine
cell line, is often used as a vehicle in the production of
pharmaceutical proteins. At present, there are many pharma-
ceutical proteins in industrial production using CHO cell
culture processes.6,7 In addition to a variety of favorable fac-
tors that aredfor exogenous gene expressiondmediated by
retroviral transfection, many protein drugs are expressed
through the retrovirus-mediated transfection in CHO cells.8
The process of XMulV entering into CHO cells has been
studied in Coˆte´ et al’s research.9 In their study, entry of
XMulV particles into CHO cells and titers of XMRV Env
pseudovirions in CHO cells were investigated.
Virus replication abides by single-step growth (or one-step
growth). A typical single-step growth analysis includes four
phases: initial phase, eclipse phase, synthetic phase, and latent
phase. The initial phase is the moment of viral attachment to a
receptor on cell membrane. The eclipse phase is the stage in
which the uncoated virus is detected. The virus is noninfectiousduring this period, because it cannot connect with receptors on
host cells. The synthetic phase is the period duringwhich virions
are assembled. The latent phase is also called the plateau stage,
during which the virus particle is no longer increased.
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electron microscopy, infection assays, PCR, and enzyme-
linked immunosorbent assay. Nowadays, the PCR assay is a
popular method of detecting viruses, especially real-time PCR.
Lute et al,10 Shi et al,11 and Wit et al 12 used the Taqman
prober to detect XMulV particles in CHO cells for the purpose
of evaluating viral clearance; the limit of detection in their
experiments ranged from 1.0 to 1.5 viral RNA copies/mL.
In this study, the SYBR Green fluorescence qPCR was used
to detect virions, and the quantity of virions on different days
was calculated using the 2DDCt method. The development of
XMulV particles cocultured with CHO cells is a typical single-
step growth observed in the relative quantityetime plot. The
amount of virions in CHO cells began to increase on Day 5 and
showed an exponential growth frequency from Day 6 to Day 7.
Early studies have demonstrated that reverse transcriptase is
contained in CHO cells.1 Lie and his team13 separated
full-length gamma proviruses in CHO cells. The Env region had
been sequenced in proviruses and the amplified complete env
gene via PCR. However, Anderson et al,14 using electron mi-
croscopy, have shown that there were deficient viruses in CHO
cells. In our study, the gag gene was selected as the target gene.
The reason for this choice was that there are three opening
reading frames in retroviral genome: gag, pol, and env. gag,
short for group-specific antigen, codes for core and structural
proteins of the virus. Moreover, gag and pol make up the
gagepol gene community to code for reverse transcriptase.
Therefore, the gag gene is seen as the sign of retroviruses.15,16
The PG-4 SþL assay was used to detect the activity of
XMulV produced on CHO cells. Intrinsically, there are murine
sarcoma viruses (MSVs) in PG-4 cells. When infected with
murine leukemia viruses (MLVs), the PG-4 cells develop and
produce pathological changes. Such dual infection by MSV
and MLVof PG-4 cells causes a detectable cytopathic effect to
estimate the infectivity of MLV.17,18 In our SþL assay, the
titer of XMulV produced on CHO cells on Day 7 was
8.78  0.25 log10 PFU/mL. The titer of the viral stock is more
than 7 log10, which satisfies the basic requirement as recom-
mended in biological products guidelines.
M. dunni cells and mink lung cells are always used as the
host organisms for the propagation of XMulV, which are used
in the evaluation of viral clearance at a laboratory scale in
CHO-derived pharmaceutical proteins. Here, the CHO cell
line is presented as a host cell for XMulV particles. The CHO
cell line is used much more frequently in studies and is more
familiar to laboratory researchers than M. dunni cells or mink
lung cells. The cell line is easy to obtain, so it is convenient for
researchers to passage XMulV particles and perform related
studies. Furthermore, XMulV propagated on CHO cells
(which was used for the evaluation of viral clearance in a
validation study) and was closer to the endogenous virus
contained in CHO cells. In addition, the study on the growth
curve of XMulV on CHO cells is helpful not only for the
collection of the virus, but also for virus transfection studies.In conclusion, the CHO cell served as a host cell for
XMulV particles and viral suspension harvested from CHO
cells on Day 7, and can be used for the evaluation of viral
clearance at a laboratory scale in pharmaceutical proteins
derived from CHO cells.
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